cas 1115338-24-3|| where to buy 2-(azepan-1-yl)-3-[(4-chlorophenyl)methanesulfonyl]quinoxaline

Produktname:2-(azepan-1-yl)-3-[(4-chlorophenyl)methanesulfonyl]quinoxaline

IUPAC Name:2-(azepan-1-yl)-3-[(4-chlorophenyl)methanesulfonyl]quinoxaline

: CAS：1115338-24-3; Molekulare Formel：C21H22ClN3O2S; Reinheit：95%+

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1115338-24-3 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:1115338-24-3; Molekulare Formel:C21H22ClN3O2S; Schmelzpunkt:-; SMILES-Code:ClC1=CC=C(CS(=O)(=O)C2=C(N=C3C=CC=CC3=N2)N2CCCCCC2)C=C1; Dichte:

: Katalognummer:CM821085; Molekulargewicht:415.94; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Quinoxalines; Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

: Azepanes; The use of azepane as a scaffold for drug discovery remains of interest. The azepane linker is the key to efficient activity. A number of seven-membered ring derivatives have been prepared or investigated for their potential or actual pharmacological properties. Examples include azaalkane derivatives as PKB (protein kinase B) inhibitors.